New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Veeva Systems Inc.
VEEV
Shape
US Flag

NYSE

34B

Medical - Healthcare Information Services

Next Earning date - 04 Dec 2024

34B

Medical - Healthcare Information Services

Next Earning date - 04 Dec 2024

212.13USD
Shape-0.10 ( -0.05%)
favorite-chart

Relative Strenght

34
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

10%

Quote Panel

Shape
Updated October 28, 2024
1W -3.36 % 1M 1.10 % 3M 10.70 % 1Y 11.50 %

Key Metrics

Shape
  • Market Cap

    34.35B


  • Shares Outstanding

    161.93M


  • Share in Float

    147.48M


  • Dividende

    0


  • Earning Date

    04 Dec 2024


  • Price Target

    212.13


  • Average Volume

    848871


  • Beta

    0.808


  • Range

    162.72-236.9


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.veeva.com


  • Sector

    Healthcare


Fundamentals

Shape

36.33x

P/E Ratio

13.35x

P/S Ratio

6.62x

P/B Ratio

0.0

Debt/Equity

23.9%

Net Margin

$3.8

EPS

How VEEV compares to sector?

P/E Ratio

Relative Strength

Shape

VEEV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape300%

2025-Revenue

$4.03

Shape280%

2025-EPS

$690M

Shape283%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Exane BNP Paribas

initialise

Previous: Not converted

2024-10-08

Now: Outperform

BTIG

initialise

Previous: Not converted

2024-07-09

Now: Buy

Barclays

upgrade

Previous: Equal-Weight

2023-01-04

Now: Overweight

Cowen & Co.

initialise

Previous: Not converted

2022-12-06

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+16%

1.13
vs 0.97

Q1.23

arrow
arrow

+28%

1.15
vs 0.9

Q2.23

arrow
arrow

-8%

0.91
vs 0.99

Q3.23

arrow
arrow

+17%

1.21
vs 1.03

Q4.23

arrow
arrow

+19%

1.34
vs 1.13

Q1.24

arrow
arrow

+20%

1.38
vs 1.15

Q2.24

arrow
arrow

+65%

1.5
vs 0.91

Q3.24

arrow
arrow

+34%

1.62
vs 1.21

Q4.24

arrow
arrow

+18%

1.58
vs 1.34

Q1.25

arrow
arrow

+11%

1.54
vs 1.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+16%

552.4M  vs 476.1M

Q1.23

arrow
arrow

+16%

563.4M  vs 485.5M

Q2.23

arrow
arrow

+4%

526.3M  vs 505.1M

Q3.23

arrow
arrow

+10%

590.2M  vs 534.2M

Q4.23

arrow
arrow

+12%

616.5M  vs 552.4M

Q1.24

arrow
arrow

+12%

630.6M  vs 563.4M

Q2.24

arrow
arrow

+24%

650.3M  vs 526.3M

Q3.24

arrow
arrow

+15%

676.2M  vs 590.2M

Q4.24

arrow
arrow

+11%

684.2M  vs 616.5M

Q1.25

arrow
arrow

+11%

697.8M  vs 630.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+3%

0.03
vs 0.03

Q1.23

arrow
arrow

+5%

0.05
vs 0.03

Q2.23

arrow
arrow

+3%

0.03
vs 0.05

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

749

749
vs 759

-1%

Q4.22

arrow
arrow

788

788
vs 749

5%

Q1.23

arrow
arrow

806

806
vs 788

2%

Q2.23

arrow
arrow

835

835
vs 806

4%

Q3.23

arrow
arrow

843

843
vs 835

1%

Q4.23

arrow
arrow

893

893
vs 843

6%

Q1.24

arrow
arrow

937

937
vs 893

5%

Q2.24

arrow
arrow

923

923
vs 937

-1%

Earnings Growth

Latest News